CD4 and neoplasm: CIITA-driven MHC-II-expressing tumor cells have a potential to induce a potent TH immune response through a diverse antigenic repertoire and consequently, to a transformation of the tumor microenvironment from a noninflamed to an inflamed phenotype, associated with infiltration of both CD4+ and CD8+ T cells (20).